CellPoint

CellPoint B.V. specializes in providing CAR T cell therapies directly at the point of care, aiming to make these treatments more accessible and affordable for patients in need. The company operates within the healthcare sector, focusing on cancer treatment by engineering T cells to target cancer cells effectively. CellPoint's business model revolves around local manufacturing and closed, automated processing systems that eliminate complex logistics, thereby reducing costs and treatment times. The company collaborates with hospitals across the EU and US, selecting clinical centers of excellence to ensure high-quality care. By leveraging a secure online platform for real-time monitoring, CellPoint ensures efficient and scalable operations. The company generates revenue by offering these advanced therapies to healthcare providers, who in turn treat patients with a quick turnaround time of just one week. Key aspects of their service include quality assurance, central supplies, and comprehensive support by CellPoint staff.

Keywords: CAR T cell therapy, point of care, cancer treatment, local manufacturing, automated processing, clinical centers, patient safety, healthcare, real-time monitoring, cost reduction.